Cellular immunity to Epstein-Barr virus in liver transplant recipients treated with rituximab for post-transplant lymphoproliferative disease. [electronic resource]
Producer: 20050602Description: 566-72 p. digitalISSN:- 1600-6135
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- pharmacology
- Child
- Child, Preschool
- DNA, Viral -- metabolism
- Epstein-Barr Virus Infections -- immunology
- Female
- Herpesvirus 4, Human -- genetics
- Humans
- Immunity, Cellular -- drug effects
- Liver Transplantation
- Lymphoproliferative Disorders -- drug therapy
- Male
- Rituximab
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.